Insulin Pump Therapy

The motion

That the Parliament acknowledges the Scottish Government's aims regarding the integration of continuous subcutaneous insulin infusion (CSII), or insulin pump therapy, in the treatment of type 1 diabetes, whereby a quarter of young Scots with type 1 diabetes will have access to the therapy, tripling the number of insulin pumps made available to more than 2,000 by 2013; highlights the lack of availability of insulin pump therapy in Scotland, where 27,910 people have type 1 diabetes and what it considers a degrading 696 (2.5%) receive CSII therapy, compared with NICE guidelines, which suggest that between 4 and 14% of patients will benefit from the therapy, which involves a programmable device delivering insulin at a continuous rate to the body; considers that insulin pump therapy offers significant health and social advantages compared with the conventional treatment of multiple daily insulin regimens with CSII proven to reduce the risk of sever hypoglycaemia attacks and improve the patient’s quality of life due to the less disruptive and self-management nature of the therapy; highlights the progress of NHS Ayrshire and Arran in promoting self-management of diabetes and increasing the availability of CSII treatments, where a further 15 healthcare professionals have been trained on nationally accredited pump courses, delivering CSII treatment to 17 adults (0.9%) and 19 children (7.3%), with an additional 15 adults and six children set to commence CSII therapy in 2012, and considers that there is a need to further increase the availability and maintain the quality healthcare treatment of insulin pump therapy across NHS boards in order to achieve the 2013 target.

No recorded vote on this motion. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.

SNP 21 Con 3 Lab 1 Green 1

Party shown is each supporter’s party when the motion was published.

No contribution in the Official Report cites S4M-01847 by reference.